// June 26, 2023
Complex generics: Are global regulators addressing the needs?
The development of generic versions of innovator medicines is a global public health need.
The development of generic versions of innovator medicines is a global public health need.
USP Principal Scientific Liaison Margareth Marques, Ph.D., provides answers to questi
Validation and verification of analytical procedures are quality assurance activities with broad
Millions of consumers rely on over-the-counter (OTC) drug products every day to address an assort